What the company does
Equillium, Inc., a clinical-stage biotechnology company, develops and sells products to treat severe autoimmune and inflammatory or immuno-inflammatory disorders with unmet medical needs. The company is headquartered in La Jolla, California.
What the weekly tape is saying
EQ closed the latest completed week at 2.81 USD. The 4-week return is 28.9% and the 12-week return is 31.9%. Trend Signal is active, Market Dynamics is 0.91. Setup signature: Balanced read with a 69/100 composite read.
A compressed read of the whole setup
The radar blends trend persistence, momentum, Market Dynamics, Relative Strength, volume confirmation, and risk control into one weekly cockpit.
Scoreboard
16-week signal tape
Price, Trend Line, and Fair Value
Weekly price context with the latest close, trend position, Fair Value gap, drawdown, and 52-week range location.
52-week price path
Price map
- Trend Line
- 1.78 USD
- Vs Trend Line
- 58.1%
- Fair Value
- 1.12 USD
- Vs Fair Value
- 151.1%
- 52W High
- 3.45 USD
- 52W Low
- 0.27 USD
- Drawdown
- -18.6%
- Range Position
- 79.9%
Returns and trend persistence
Return windows separate the latest week from short-term and medium-term follow-through.
Return windows
Trend read
- Active Streak
- 14 weeks
- 52W Active Weeks
- 40
- 52W Active Breadth
- 76.9%
- Sector Scope
- US Healthcare
- Sector Rank
- 812 of 1038
- Sector Percentile
- 21.8%
Sector and industry pulse
Peer breadth helps separate a stock-specific move from a broader group rotation.
US Healthcare
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 0.8%
- Avg 4W
- 3.5%
- Trend Breadth
- 33.0%
- Positive MD
- 41.0%
US Biotechnology
- Tracked Peers
- 100
- 4W Rank
- - of 100
- Avg 1W
- 4.9%
- Avg 4W
- 1.7%
- Trend Breadth
- 46.0%
- Positive RS
- 47.0%
Pressure, Relative Strength, and expectation
Market Dynamics and Relative Strength show whether buying pressure and relative leadership are confirming the price move.
Dynamics path
Signal state
- Market Dynamics
- 0.91
- 4W MD Change
- 117.4%
- Relative Strength
- 63.00
- 4W RS Change
- 47.6%
- Expectation
- Undecided
- Probability
- 49.21%
Participation and confirmation
Volume tells us whether the latest weekly move is being confirmed by unusual participation.
52-week volume profile
Volume map
- Latest Volume
- 2.5M
- 13W Average
- 3.0M
- 52W Average
- 12.0M
- Vs 13W
- 0.8x
- Vs 52W
- 0.2x
Volatility, downside weeks, and return shape
A compact risk profile shows whether the move is steady, volatile, or being driven by sharp one-week jumps.
26-week return distribution
Risk map
- 13W Volatility
- 10.7%
- 52W Volatility
- 26.2%
- Upside Weeks
- 29
- Downside Weeks
- 22
- Downside Breadth
- 42.3%
- Avg Gain / Loss
- 19.3% / -9.9%
Classification, opportunities, risks, and watch points
Top-level read across company classification, constructive evidence, caution points, and the next things that matter.
Classification
- Exchange
- NASDAQ
- Country
- US
- Sector
- Healthcare
- Industry
- Biotechnology
- Currency
- USD
- Market Cap
- 183.4M
Opportunity signals
- Trend Signal is active with a 14-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Market Dynamics is positive on the latest completed week.
Risk signals
- No major top-level risk cluster is currently dominant.
Watch next
- Trend Line remains the key weekly regime level.
- Market Dynamics is the pressure gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Recent completed weeks
The latest weekly rows behind the report snapshot.
| Week | Close | Return | Trend | Fair Value | MD | RS | Volume | Signal |
|---|---|---|---|---|---|---|---|---|
| 12 Jun 2026 | 2.81 USD | -4.4% | 1.78 USD | 1.12 USD | 0.91 | 63.00 | 2.5M | On |
| 5 Jun 2026 | 2.94 USD | 1.4% | 1.72 USD | 1.11 USD | 0.73 | 79.14 | 14.6M | On |
| 29 May 2026 | 2.90 USD | 28.3% | 1.66 USD | 1.09 USD | 0.47 | 73.69 | 3.8M | On |
| 22 May 2026 | 2.26 USD | 3.7% | 1.61 USD | 1.08 USD | 0.28 | 43.14 | 1.7M | On |
| 15 May 2026 | 2.18 USD | 3.3% | 1.58 USD | 1.07 USD | 0.42 | 42.68 | 1.6M | On |
| 8 May 2026 | 2.11 USD | 1.4% | 1.55 USD | 1.06 USD | 0.53 | 40.61 | 850.7K | On |
| 1 May 2026 | 2.08 USD | -3.7% | 1.53 USD | 1.05 USD | 0.51 | 49.17 | 997.3K | On |
| 24 Apr 2026 | 2.16 USD | 5.4% | 1.50 USD | 1.04 USD | 0.54 | 60.62 | 2.7M | On |
| 17 Apr 2026 | 2.05 USD | 13.9% | 1.48 USD | 1.03 USD | 0.46 | 59.49 | 2.2M | On |
| 10 Apr 2026 | 1.80 USD | -8.6% | 1.46 USD | 1.02 USD | 0.51 | 51.78 | 1.6M | On |
| 2 Apr 2026 | 1.97 USD | 4.8% | 1.46 USD | 1.01 USD | 0.79 | 76.83 | 1.6M | On |
| 27 Mar 2026 | 1.88 USD | -11.7% | 1.46 USD | 1.00 USD | 0.84 | 79.53 | 1.9M | On |
| 20 Mar 2026 | 2.13 USD | -13.8% | 1.46 USD | 1.00 USD | 0.87 | 102.01 | 2.8M | On |
| 13 Mar 2026 | 2.47 USD | 39.5% | 1.45 USD | 0.99 USD | 0.80 | 134.75 | 6.8M | On |